The loss of Mos in mouse leads to parthenogenesis and to the development of ovarian teratomas [13, 14], consistent with the idea that mos could be considered as a meiotic tumour-suppressor gene whereas its activity as an oncoprotein is well established in somatic cells. This evidence concerns the gene MOS and ovarian teratoma.